Cargando…

Risk assessment regarding the use of Annona muricata in food supplements

The current risk assessment was performed in the context of the European Food Risk Assessment Fellowship Programme (EU‐FORA) supported by EFSA and was intended to evaluate possible health risks associated with the consumption of Annona muricata L. (Annonaceae) and derived food supplements. A. murica...

Descripción completa

Detalles Bibliográficos
Autores principales: Raclariu‐Manolica, Ancuta Cristina, Bakhiya, Nadiya, Hirsch‐Ernst, Karen Ildico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691614/
https://www.ncbi.nlm.nih.gov/pubmed/33294051
http://dx.doi.org/10.2903/j.efsa.2020.e181112
_version_ 1783614331584249856
author Raclariu‐Manolica, Ancuta Cristina
Bakhiya, Nadiya
Hirsch‐Ernst, Karen Ildico
author_facet Raclariu‐Manolica, Ancuta Cristina
Bakhiya, Nadiya
Hirsch‐Ernst, Karen Ildico
collection PubMed
description The current risk assessment was performed in the context of the European Food Risk Assessment Fellowship Programme (EU‐FORA) supported by EFSA and was intended to evaluate possible health risks associated with the consumption of Annona muricata L. (Annonaceae) and derived food supplements. A. muricata grows as a tree and is native to the Caribbean and Central America. Preparations made from different plant parts of A. muricata (i.e. fruit, leaves, bark, roots) have been used as herbal medicine and are also marketed worldwide as over‐the‐counter food supplements that have been purported to support general health or to treat a wide range of health conditions, particularly cancer and parasitic infections. However, open questions remain regarding the safety of A. muricata‐based food supplements, since Annonaceae have been reported to contain potentially neurotoxic compounds, i.e. acetogenins. The assessment conducted within the present fellowship programme shows that substantial uncertainties exist regarding the safe use of A. muricata‐based supplements. The available data provide indications of neurotoxic potential of certain A. muricata preparations. The paucity of adequate studies, particularly related to long‐term use of A. muricata supplements, currently does not allow the establishment of a safe intake level. Within this technical report a workflow of the project is presented.
format Online
Article
Text
id pubmed-7691614
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76916142020-12-07 Risk assessment regarding the use of Annona muricata in food supplements Raclariu‐Manolica, Ancuta Cristina Bakhiya, Nadiya Hirsch‐Ernst, Karen Ildico EFSA J EU‐FORA Series 3 The current risk assessment was performed in the context of the European Food Risk Assessment Fellowship Programme (EU‐FORA) supported by EFSA and was intended to evaluate possible health risks associated with the consumption of Annona muricata L. (Annonaceae) and derived food supplements. A. muricata grows as a tree and is native to the Caribbean and Central America. Preparations made from different plant parts of A. muricata (i.e. fruit, leaves, bark, roots) have been used as herbal medicine and are also marketed worldwide as over‐the‐counter food supplements that have been purported to support general health or to treat a wide range of health conditions, particularly cancer and parasitic infections. However, open questions remain regarding the safety of A. muricata‐based food supplements, since Annonaceae have been reported to contain potentially neurotoxic compounds, i.e. acetogenins. The assessment conducted within the present fellowship programme shows that substantial uncertainties exist regarding the safe use of A. muricata‐based supplements. The available data provide indications of neurotoxic potential of certain A. muricata preparations. The paucity of adequate studies, particularly related to long‐term use of A. muricata supplements, currently does not allow the establishment of a safe intake level. Within this technical report a workflow of the project is presented. John Wiley and Sons Inc. 2020-11-26 /pmc/articles/PMC7691614/ /pubmed/33294051 http://dx.doi.org/10.2903/j.efsa.2020.e181112 Text en © 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle EU‐FORA Series 3
Raclariu‐Manolica, Ancuta Cristina
Bakhiya, Nadiya
Hirsch‐Ernst, Karen Ildico
Risk assessment regarding the use of Annona muricata in food supplements
title Risk assessment regarding the use of Annona muricata in food supplements
title_full Risk assessment regarding the use of Annona muricata in food supplements
title_fullStr Risk assessment regarding the use of Annona muricata in food supplements
title_full_unstemmed Risk assessment regarding the use of Annona muricata in food supplements
title_short Risk assessment regarding the use of Annona muricata in food supplements
title_sort risk assessment regarding the use of annona muricata in food supplements
topic EU‐FORA Series 3
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691614/
https://www.ncbi.nlm.nih.gov/pubmed/33294051
http://dx.doi.org/10.2903/j.efsa.2020.e181112
work_keys_str_mv AT riskassessmentregardingtheuseofannonamuricatainfoodsupplements
AT raclariumanolicaancutacristina riskassessmentregardingtheuseofannonamuricatainfoodsupplements
AT bakhiyanadiya riskassessmentregardingtheuseofannonamuricatainfoodsupplements
AT hirschernstkarenildico riskassessmentregardingtheuseofannonamuricatainfoodsupplements